Last: | $99.53 |
---|---|
Change Percent: | -2.19% |
Open: | $100.62 |
Close: | $99.53 |
High: | $100.62 |
Low: | $96.96 |
Volume: | 339,066 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$99.53 | $100.62 | $99.53 | $100.62 | $96.96 | 339,066 | 05-03-2024 |
$98.46 | $98.47 | $98.46 | $102.73 | $97.99 | 625,333 | 05-02-2024 |
$93.54 | $95.34 | $93.54 | $96.355 | $93.07 | 999,022 | 05-01-2024 |
$94.49 | $94.82 | $94.49 | $95.27 | $94.21 | 241,598 | 04-30-2024 |
$95.27 | $94.37 | $95.27 | $96.01 | $94.37 | 249,907 | 04-29-2024 |
$94.09 | $95.46 | $94.09 | $96.035 | $93.85 | 288,866 | 04-26-2024 |
$95.3 | $95.38 | $95.3 | $96.41 | $93.27 | 307,023 | 04-25-2024 |
$95.94 | $95.36 | $95.94 | $96.165 | $94.04 | 178,478 | 04-24-2024 |
$95.85 | $95.3 | $95.85 | $96.82 | $95.3 | 146,121 | 04-23-2024 |
$95.4 | $92.71 | $95.4 | $95.84 | $92.12 | 299,409 | 04-22-2024 |
$91.76 | $91.27 | $91.76 | $92.39 | $91.205 | 260,500 | 04-19-2024 |
$91.25 | $92.59 | $91.25 | $92.59 | $90.95 | 272,733 | 04-18-2024 |
$92.22 | $92.6 | $92.22 | $93.6 | $92.08 | 162,144 | 04-17-2024 |
$92.15 | $91.49 | $92.15 | $92.72 | $91.29 | 134,765 | 04-16-2024 |
$92.16 | $93.31 | $92.16 | $93.96 | $91.91 | 170,968 | 04-15-2024 |
$93.02 | $95.34 | $93.02 | $95.75 | $92.89 | 315,922 | 04-12-2024 |
$95.95 | $96.16 | $95.95 | $96.97 | $95.335 | 258,697 | 04-11-2024 |
$96.28 | $96.58 | $96.28 | $97.38 | $95.6 | 220,029 | 04-10-2024 |
$97.46 | $96.91 | $97.46 | $97.47 | $95.665 | 365,723 | 04-09-2024 |
$97 | $97.32 | $97 | $97.72 | $96.62 | 195,263 | 04-08-2024 |
News, Short Squeeze, Breakout and More Instantly...
PJT Partners Inc. Class A Company Name:
PJT Stock Symbol:
NYSE Market:
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
Placental Mucosal Associated Invariant T (MAIT) cells are unique unconventional immune T cells which are particularly suitable for the treatment of solid tumors, a significant unmet medical need MAIT cells offer unique advantages compared to conventional T cells MAIT cells hold immense po...
First Quarter Overview Record First Quarter Revenues of $329 million, an increase of 65% from a year ago GAAP Pretax Income of $54 million and Adjusted Pretax Income of $55 million, an increase of 85% and 81%, respectively, from a year ago GAAP Diluted EPS of $1.22 and Adjusted EP...